Your browser doesn't support javascript.
loading
A study on blocking store-operated Ca2+ entry in pulmonary arterial smooth muscle cells with xyloketals from marine fungi.
Zhou, Jie-Bin; Sun, Ying-Ying; Zheng, Ying-Lin; Yu, Chu-Qin; Lin, Hua-Qing; Pang, Ji-Yan.
Affiliation
  • Zhou JB; 1School of Chemistry Sun Yat-Sen University, Guangzhou 510275, P. R. China.
  • Sun YY; 2Department of Guangdong Key Laboratory for New Pharmaceutical Dosage Forms GuangDong Pharmaceutical University, Guangzhou 510006, P. R. China.
  • Zheng YL; 1School of Chemistry Sun Yat-Sen University, Guangzhou 510275, P. R. China.
  • Yu CQ; 2Department of Guangdong Key Laboratory for New Pharmaceutical Dosage Forms GuangDong Pharmaceutical University, Guangzhou 510006, P. R. China.
  • Lin HQ; 2Department of Guangdong Key Laboratory for New Pharmaceutical Dosage Forms GuangDong Pharmaceutical University, Guangzhou 510006, P. R. China.
  • Pang JY; 1School of Chemistry Sun Yat-Sen University, Guangzhou 510275, P. R. China.
Acta Pharm ; 67(4): 557-567, 2017 Dec 20.
Article in En | MEDLINE | ID: mdl-29337674
ABSTRACT
In this study, the effect of four xyloketals 1-4 on store-operated calcium entry (SOCE) was investigated in primary distal pulmonary arterial smooth muscle cells (PASMCs) isolated from mice. The results showed that xyloketal A (1), an unusual ketal with C-3 symmetry, exhibited strong SOCE blocking activity. Secretion of interleukin-8 (IL-8) was also inhibited by xyloketal A. The parallel artificial membrane permeability assay (PAMPA) of 1-4 suggested that these xyloketals penetrated easily through the cell membrane. Moreover, the molecular docking study of xyloketal A with activation region of the stromal interaction molecule (STIM) 1 and the calcium release-activated calcium modulator (ORAI) 1 (STIM1-ORAI1) protein complex, the key domain of SOCE, revealed that xyloketal A exhibited a noncovalent interaction with the key residue lysine 363 (LYS363) in the identified cytosolic regions in STIM1-C. These findings provided useful information about xyloketal A as a SOCE inhibitor for further evaluation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Artery / Pyrans / Xylariales / Calcium Release Activated Calcium Channels / Muscle, Smooth, Vascular Type of study: Prognostic_studies Limits: Animals Language: En Journal: Acta Pharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Artery / Pyrans / Xylariales / Calcium Release Activated Calcium Channels / Muscle, Smooth, Vascular Type of study: Prognostic_studies Limits: Animals Language: En Journal: Acta Pharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2017 Document type: Article